Skip to main content
NCD 250.1 · version 1

NCD 250.1: Treatment of Psoriasis

Compiled from CMS files by the QuickIntell RCM Editorial Team · Data effective · Method: reference methodology · Report a data correction

Data currency: Medicare Coverage Database NCDs: API snapshot September 27, 2026 (effective September 20, 2026). Next CMS release: weekly, every Thursday.

Medicare Coverage Database NCDs: the loaded version is API snapshot September 27, 2026, and the CMS schedule called for a newer one from October 1, 2026. Verify figures against the current CMS publication until this reference is rebuilt; pages built on it are withdrawn from search indexing until then.

Key facts for NCD 250.1

Benefit category
Incident to a physician's professional Service, Physicians' Services
Effective date
Longstanding NCD
Date of this version not posted by CMS
Transmittal
n/a
Versions published
1
Manual section
250
Skin, NCD Manual (Pub. 100-03) chapter 1 part 4

TL;DR

NCD 250.1 sets Medicare's national policy for treatment of psoriasis under the benefit category "Incident to a physician's professional Service, Physicians' Services", as a longstanding NCD (CMS has not posted the effective date of its current version). Psoriasis is a chronic skin disease, for which several conventional methods of treatment have been recognized as covered. These include topical application of steroids or other drugs; ultraviolet light (actinotherapy); and coal tar alone or in combination… It has been revised once since publication and binds every Medicare Administrative Contractor nationally.

Indications and limitations of coverage

Psoriasis is a chronic skin disease, for which several conventional methods of treatment have been recognized as covered. These include topical application of steroids or other drugs; ultraviolet light (actinotherapy); and coal tar alone or in combination with ultraviolet B light (Goeckerman treatment).

A newer treatment for psoriasis uses a psoralen derivative drug in combination with ultraviolet A light, known as PUVA. PUVA therapy is covered for treatment of intractable, disabling psoriasis, but only after the psoriasis has not responded to more conventional treatment. The Medicare Administrative Contractor should document this before paying for PUVA therapy.

In addition, reimbursement for PUVA therapy should be limited to amounts paid for other types of photochemotherapy; ordinarily, payment should not be allowed for more than 30 days of treatment, unless improvement is documented.

Text reproduced from the CMS Medicare Coverage Database record for NCD 250.1 version 1. View the original on cms.gov.

Local policies that build on this NCD

1 active Local Coverage Determination cites NCD 250.1 among its related national policies. An LCD may not conflict with the national determination; read it for the contractor's documentation and coding detail in that jurisdiction.

How MACs bill NCD 250.1

A National Coverage Determination states the policy; the Medicare Administrative Contractors publish the articles that turn it into claim edits. 1 current article in the Medicare Coverage Database names NCD 250.1, 1 of them with a covered ICD-10-CM list, from 1 contractor. The lists can differ by contractor even though the NCD is national, because each MAC codes the policy for its own claims system; check the article of the contractor that processes the claim.

Contractors with articles that implement NCD 250.1
ContractorArticles
CGS Administrators, LLCA57311

A57311: Billing and Coding: Physical Therapy - Home Health

Billing and Coding, effective 2026-08-06 · CGS Administrators, LLC (15004) · CMS record

14,836 covered ICD-10-CM codes; 50 procedure codes: 95851, 95852, 97010, 97012, 97016, 97018, 97022, 97024, 97026, 97028, 97032, 97033 and 38 more. Local policy: L33942 Physical Therapy - Home Health. Check a diagnosis for 95851.

First covered codes: B91 Sequelae of poliomyelitis; E08.44 Diabetes mellitus due to underlying condition with diabetic amyotrophy; E08.52 Diabetes mellitus due to underlying condition with diabetic peripheral angiopathy with gangrene; E09.44 Drug or chemical induced diabetes mellitus with neurological complications with diabetic amyotrophy; E09.52 Drug or chemical induced diabetes mellitus with diabetic peripheral angiopathy with gangrene; E10.44 Type 1 diabetes mellitus with diabetic amyotrophy; …

How this NCD shows up on remittances

A service denied under a National Coverage Determination returns CARC 50 (not deemed medically necessary) with remark N386 (decision based on an NCD); a denial citing a local policy instead carries N115. Because NCDs bind nationally, the appeal path is documentation that the patient meets the indications above, not a contractor-policy argument.

For teams evaluating QuickIntell software

Evaluate a coverage-review workflow around NCD 250.1

Explore QuickAuth for requirement checks, documentation preparation and status tracking with staff oversight. Bring the policy-review steps your team repeats to a scoped evaluation, and confirm plan-specific requirements and supported actions. Use QuickRCM to evaluate the separate claim and denial workflow; a published NCD is not an authorization or payment guarantee.

Optional software evaluation, not payer support or help with an individual claim. For coverage or payment decisions, use the official sources on this page. Do not include patient information in a demo booking or inquiry.

Frequently asked questions — NCD 250.1

What does NCD 250.1 cover?

Psoriasis is a chronic skin disease, for which several conventional methods of treatment have been recognized as covered. These include topical application of steroids or other drugs; ultraviolet light (actinotherapy); and coal tar alone or in combination with ultraviolet B light (Goeckerman treatment). The full indications and limitations are reproduced on this page from the CMS Medicare Coverage Database.

When did NCD 250.1 take effect?

NCD 250.1 is a longstanding NCD (CMS has not posted the effective date of its current version); the current version is 1. This is the only published version.

Does a Local Coverage Determination override NCD 250.1?

No. A National Coverage Determination binds all Medicare Administrative Contractors; an LCD can only address services or circumstances the NCD leaves open. Claims denied under this NCD typically return CARC 50 with remark N386 (NCD) rather than N115 (LCD).

Sources

Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-11-16. Verify against the primary file before billing or contracting decisions. The reference methodology explains how each figure is computed from these files.

Disclaimer

This page reproduces the CMS National Coverage Determination text and, for laboratory NCDs, the CMS ICD-10 edit lists, as an operational reference. Coverage decisions depend on the full policy, the claim and the contractor; nothing here is legal, clinical or billing advice. CPT codes are shown as numbers only; CPT descriptors are copyright AMA.

Found a figure that does not match the CMS file? Report a data correction with the CMS file and the value you expected; the request reaches the editorial team through the contact form.